Award
National Cancer Institute 1R44CA306750-01
Lung Cancer FAST (Fragment Analysis, SNP, and Translocations) Testing
Recipient
Not specified
Award Amount
$764,448.00
Ceiling
$764,448.00
Awarded
August 27, 2025
Identifier
1R44CA306750-01
Award for development and clinical validation of Lung-FAST, a PCR-based lung cancer test, including clinical sample validation, kit development, and FDA submission preparation.
Description
This project involves the development and clinical validation of Lung-FAST, a PCR-based test for detecting actionable mutations in lung cancer. The project aims to validate the test on clinical samples, develop a clinical-grade kit, and prepare for FDA submission.